학술논문
Phase II study of SOXIRI (S-1/oxaliplatin/irinotecan) chemotherapy in patients with unresectable pancreatic ductal adenocarcinoma
Document Type
Article
Author
Source
In Pancreatology March 2024 24(2):241-248
Subject
Language
ISSN
1424-3903